Research and Knowledge Translation

 
Research

Welcome to the Mid North Coast Local Health District’s (MNCLHD) Research and Knowledge Translation Website. The MNCLHD Governing Board and Chief Executive are keen to promote and foster a culture of research on the MNC. Research will benefit our local area through the attraction, recruitment and retention of highly skilled clinicians with an interest in research and develop projects that are specific and will benefit OUR community and healthcare system.

Contact Us:

MNCLHD-Research@health.nsw.gov.au

Phone 02 5524 2490

What’s new?

COVID – 19 information for researchers, clinicians and research partners

During the Covid-19 pandemic researchers may need to consider changes in the methods and ability to conduct research. Consideration needs to be given to participants’ needs due to self-isolation, travel restrictions, site visit limitations and safety for both participants and staff.

Guidance for research within the MNCLHD may be found in the following levels:

Local

MNCLHD-specific measures for COVID-19 interruption to Clinical Trials and non-drug research

This guidance is to be read in conjunction with State guidance documents. It is recommended to liaise with the Research Governance Officer or Research Office for guidance.

State

NSW Health COVID-19 Guidance on Clinical Trials: Guidance for clinical trial sponsors, sites and researchers

This guidance has been provided to minimise the adverse health impacts on clinical trial participants as well as site, sponsor and vendor staff involved in clinical trials. Emphasis is placed on managing burden and disruption to health-related services in NSW at this critical time.

National

COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors.

This guidance provides general information and advice to institutions conducting or overseeing research, Human Research Ethics Committees (HRECs), researchers and sponsors in the context of the COVID-19 pandemic. It is directed towards those involved in clinical trial research and other relevant clinical research, but also may be of use to institutions, HRECs and researchers in other fields.

Updates on other key research initiatives:

Updates to this information will be provided as the situation evolves. If you have any questions in relation to research during COVID-19 pandemic, please contact research governance or the Research Office